Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Wild cranberry (Vaccinium oxycoccos) is rich in A-type proanthocyanidins that inhibit E. coli adhesion to uroepithelial cells by blocking bacterial P-fimbriae, along with anthocyanins (cyanidin-3-galactoside, peonidin-3-galactoside) that exhibit potent antimicrobial and antioxidant activity, as confirmed by phenolic profiling studies (PMID 20173403). Research further demonstrates that wild cranberry bioactive compounds—including quercetin glycosides and chlorogenic acid—possess anti-angiogenic and anti-carcinogenic properties via suppression of oxidative stress markers and NF-κB-mediated inflammatory pathways (PMID 14972022).
Reported Benefits (Provisional)
Origin & History
Wild Cranberry (Vaccinium macrocarpon) is a tart, nutrient-dense berry native to the cool, temperate bogs and wetlands of Northeastern North America, particularly the United States and Canada. Revered for its potent bioactive compounds, it is a significant superfruit for supporting urinary tract health and overall wellness.
Research Narrative (Provisional)
Cesoniene et al. (2009) characterized phenolics and anthocyanins in European cranberry (V. oxycoccos), demonstrating significant antimicrobial activity against pathogenic bacteria including Staphylococcus aureus and Escherichia coli (Medicina (Kaunas), PMID 20173403). Bagchi et al. (2004) showed that an anthocyanin-rich berry extract formula containing cranberry compounds exhibited anti-angiogenic, antioxidant, and anti-carcinogenic properties in vitro, reducing VEGF expression and DNA fragmentation in cancer cell lines (Biochemistry (Mosc), PMID 14972022). Hohtola (2010) reviewed bioactive compounds from northern plants including wild cranberry, confirming their high concentrations of flavonoids, stilbenes, and phenolic acids with documented antioxidant and anti-inflammatory effects (Adv Exp Med Biol, PMID 21520706). Papakotsi et al. (2024) identified Alaskan wild cranberry species among native flora with potential anticancer applications, linking traditional ethnobotanical use to modern pharmacological evidence (Int J Biopharm Sci, PMID 39877830).
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Phytochemicals/Bioactives: Proanthocyanidins, Flavonoids (quercetin, myricetin), Polyphenols, Organic acids (benzoic acid) - Vitamins: C, E - Minerals: Manganese - Macronutrients: Dietary fiber
Reported Mechanism (Provisional)
A-type proanthocyanidins (PACs) in wild cranberry possess unique C4→C8 and C4→C6 interflavanoid bonds that specifically block P-fimbriae and type 1 pili on uropathogenic E. coli, preventing bacterial adhesion to mannose-containing glycoproteins on uroepithelial cell surfaces. Anthocyanins such as cyanidin-3-galactoside and peonidin-3-galactoside scavenge reactive oxygen species via electron donation from their B-ring hydroxyl groups and chelation of transition metals, reducing lipid peroxidation and inhibiting NADPH oxidase activity. Flavonols including quercetin-3-O-galactoside suppress NF-κB pathway activation by inhibiting IκB kinase (IKK) phosphorylation, thereby downregulating pro-inflammatory cytokines TNF-α, IL-6, and COX-2 expression. Additionally, wild cranberry phenolic acids (chlorogenic acid, caffeic acid) inhibit VEGF-mediated angiogenesis and modulate the PI3K/Akt signaling pathway, contributing to anti-carcinogenic effects observed in preclinical models (PMID 14972022).
Clinical Narrative (Provisional)
Current evidence is primarily from in vitro and preclinical studies rather than human clinical trials with quantified outcomes. Laboratory studies demonstrate proanthocyanidin concentrations of 1047-1175 µg/g in wild cranberry cultivars effectively inhibit E. coli adhesion. Ethanolic extracts show antioxidant activity with IC50 values of 61.1 µg/ml for superoxide scavenging and 54.7 µg/ml for nitric oxide scavenging. Human clinical trials with specific UTI prevention percentages and cardiovascular outcomes are needed to validate therapeutic claims.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.